Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ken Fujioka

Showing results (1-10 of 64) with videos related to

Pageof 7
Sort By:
JAAPA : Official Journal of the American Academy of Physician Assistants|January 25, 2008
Pathophysiology of type 2 diabetes and the role of incretin hormones and beta-cell dysfunctionKen Fujioka
Diabetes Care|January 29, 2005
Follow-up of nutritional and metabolic problems after bariatric surgeryKen Fujioka
Diabetes, Obesity & Metabolism|February 16, 2010
Benefits of moderate weight loss in patients with type 2 diabetesKen Fujioka
Obesity (Silver Spring, Md.)|April 23, 2015
Safety and tolerability of medications approved for chronic weight managementKen Fujioka
Obesity Research|December 20, 2002
Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical optionsKen Fujioka
Pharmacotherapy|November 28, 2006
Metabolic syndrome treatment strategiesKen Fujioka
Managed Care (Langhorne, Pa.)|April 18, 2007
Obesity epidemic: what treatments work and whom do you treat?Ken Fujioka
American Journal of Therapeutics|March 7, 2018
Effects of "Essential AD2" Supplement on Blood Acetaldehyde Levels in Individuals Who Have Aldehyde Dehydrogenase (ALDH2) DeficiencyKen Fujioka, Spencer Gordon
The Mount Sinai Journal of Medicine, New York|October 21, 2010
Office-based management of obesityKen Fujioka, Nitasha Bakhru
Diabetes Spectrum : a Publication of the American Diabetes Association|November 21, 2017
Obesity Pharmacotherapy in Patients With Type 2 DiabetesScott Kahan, Ken Fujioka
Pageof 7

Showing results (1-10 of 64) with videos related to

Sort By:
Pageof 7
JAAPA : Official Journal of the American Academy of Physician Assistants|January 25, 2008
Pathophysiology of type 2 diabetes and the role of incretin hormones and beta-cell dysfunctionKen Fujioka
Diabetes Care|January 29, 2005
Follow-up of nutritional and metabolic problems after bariatric surgeryKen Fujioka
Diabetes, Obesity & Metabolism|February 16, 2010
Benefits of moderate weight loss in patients with type 2 diabetesKen Fujioka
Obesity (Silver Spring, Md.)|April 23, 2015
Safety and tolerability of medications approved for chronic weight managementKen Fujioka
Obesity Research|December 20, 2002
Management of obesity as a chronic disease: nonpharmacologic, pharmacologic, and surgical optionsKen Fujioka
Pharmacotherapy|November 28, 2006
Metabolic syndrome treatment strategiesKen Fujioka
Managed Care (Langhorne, Pa.)|April 18, 2007
Obesity epidemic: what treatments work and whom do you treat?Ken Fujioka
American Journal of Therapeutics|March 7, 2018
Effects of "Essential AD2" Supplement on Blood Acetaldehyde Levels in Individuals Who Have Aldehyde Dehydrogenase (ALDH2) DeficiencyKen Fujioka, Spencer Gordon
The Mount Sinai Journal of Medicine, New York|October 21, 2010
Office-based management of obesityKen Fujioka, Nitasha Bakhru
Diabetes Spectrum : a Publication of the American Diabetes Association|November 21, 2017
Obesity Pharmacotherapy in Patients With Type 2 DiabetesScott Kahan, Ken Fujioka
Pageof 7